Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Website

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE-300760

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Jan '22
Jan '23
Dec '23
LTM

Operating Revenues

16,519.6

20,981

25,257.8

30,353.8

34,875.3

36,912.7

Other Revenues, Total

36.4

44.9

11.7

11.8

56.6

74

Total Revenues

16,556

21,025.8

25,269.6

30,365.6

34,931.9

36,986.7

Total Revenues % Chg.

—

20.4%

27%

20.2%

20.2%

15%

10.5%

Cost of Goods Sold, Total

5,799.2

7,459.5

8,967

10,955.6

12,075.3

12,661.7

Gross Profit

10,756.8

13,566.4

16,302.6

19,410

22,856.6

24,325

Selling General & Admin Expenses, Total

4,370.7

4,509.1

5,104.6

6,121.6

7,226.7

7,353.9

Provision for Bad Debts

8.8

29.7

-6.7

37.1

244.6

321.6

R&D Expenses

—

—

—

1,465.6

1,869.3

2,524.2

2,922.6

3,432.7

3,356.5

Other Operating Expenses

-81.8

-100.8

-83.1

-80.4

-308.8

-289.6

Other Operating Expenses, Total

5,763.3

6,307.2

7,539

9,001

10,595.1

10,742.5

Operating Income

4,993.5

7,259.1

8,763.6

10,409

12,261.5

13,582.4

Interest Expense, Total

—

—

-8.6

-10.7

-13

-16.6

Interest And Investment Income

331.3

385.7

408.1

357.9

821.6

909.2

Net Interest Expenses

331.3

385.7

399.5

347.2

808.6

892.6

Income (Loss) On Equity Invest.

—

—

—

—

—

—

-4.5

—

—

—

—

Currency Exchange Gains (Loss)

156.3

-253.4

-227.7

172

119.2

-168.5

Other Non Operating Income (Expenses)

-79.7

-70.9

-85.9

-67.8

-72.5

-65.7

EBT, Excl. Unusual Items

5,401.4

7,316.1

8,849.5

10,860.4

13,116.8

14,240.9

Impairment of Goodwill

—

—

—

—

-94.5

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

9.9

-26.4

69.6

164.5

Gain (Loss) On Sale Of Assets

-1.5

-2.1

4.1

6.2

2.5

6.1

Asset Writedown

-18.1

-16.9

-7.5

-0.7

-274.9

-274.9

Legal Settlements

2.4

-2.4

-5.7

-3.3

-12.6

-18.5

Other Unusual Items

78.5

143.7

166.8

117.5

109.7

124.6

EBT, Incl. Unusual Items

5,368.3

7,438.4

9,017.1

10,953.6

13,010.9

14,242.7

Income Tax Expense

683.4

778.8

1,013

1,342.8

1,432.5

1,531.5

Earnings From Continuing Operations

4,684.8

6,659.6

8,004

9,610.7

11,578.4

12,711.1

Minority Interest

-4.2

-1.9

-2.5

-3.5

3.8

-10.2

Net Income

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,701

Net Income to Common Incl Extra Items

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,701

Net Income to Common Excl. Extra Items

4,680.6

6,657.7

8,001.6

9,607.2

11,582.2

12,701

Total Shares Outstanding

1,215.7

1,215.7

1,212.6

1,209.4

1,214.2

1,211.2

Weighted Avg. Shares Outstanding

1,215.7

1,215.7

1,214.8

1,209.9

1,211.7

1,211.5

Weighted Avg. Shares Outstanding Dil

1,215.7

1,215.7

1,214.8

1,210.4

1,211.8

1,211.6

EPS

3.9

5.5

6.6

7.9

9.6

10.5

EPS Diluted

3.9

5.5

6.6

7.9

9.6

10.5

EBITDA

5,387.8

7,731.3

9,380.1

11,188.1

13,125.9

14,595

Effective Tax Rate

12.7%

10.5%

11.2%

12.3%

11%

10.8%